EUVIMEDEUVIMED entdecken
Crossref

Effect of Oral Deferasirox Chelation Therapy on Endocrine and Metabolic Parameters in Β-Thalassemia Major Patients Attending a Tertiary Care Hospital of Northern India

Pooja Devi, Akanksha Srivastava, Nitu Choudhary

International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)

DOI: 10.25258/ijcpr.18.6.302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Pooja Devi und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To evaluate the effect of long-term oral deferasirox therapy on endocrine and metabolic parameters in βthalassemia major patients at a tertiary care hospital in Northern India.

Methods

A cross-sectional observational study was conducted on 100 patients including case and control transfusion-dependent β-TM patients receiving oral deferasirox for at least 12 months. Data were collected on clinical characteristics, transfusion frequency, and dose regimen. Laboratory evaluation included serum ferritin, thyroid function tests (TSH, FT3, FT4), fasting plasma glucose, insulin, liver and renal function tests, serum calcium, vitamin D, parathyroidhormone, and bone mineral density (DEXA). Statistical comparisons were made with age- and sex-matched controls or baseline parameters, using paired t-test or ANOVA.

Results

Mean patient age was 8 years; mean duration of chelation was 3# years. Significant reduction of mean serum ferritin was observed (p#

Zitieren

APA

Devi, P., Srivastava, A., & Choudhary, N. (2026). Effect of Oral Deferasirox Chelation Therapy on Endocrine and Metabolic Parameters in Β-Thalassemia Major Patients Attending a Tertiary Care Hospital of Northern India. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.302

Vancouver

Devi P, Srivastava A, Choudhary N. Effect of Oral Deferasirox Chelation Therapy on Endocrine and Metabolic Parameters in Β-Thalassemia Major Patients Attending a Tertiary Care Hospital of Northern India. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.302

BibTeX
@article{Devi2026,
  author = {Devi, Pooja and Srivastava, Akanksha and Choudhary, Nitu},
  title = {Effect of Oral Deferasirox Chelation Therapy on Endocrine and Metabolic Parameters in Β-Thalassemia Major Patients Attending a Tertiary Care Hospital of Northern India},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {06},
  doi = {10.25258/ijcpr.18.6.302}
}
Kostenlos starten →